Pyloric stenosis is the probable diagnosis when a newborn experiences non-bilious vomiting during the first few weeks of life. This condition results in the loss of hydrochloric acid (HCl) from the stomach contents, leading to hypochloremia and potassium loss. The metabolic alkalosis is caused by the depletion of hydrogen ions due to the vomiting of stomach acid.

Understanding Pyloric Stenosis

Pyloric stenosis is a condition that usually occurs in infants between the second and fourth weeks of life. However, in rare cases, it may present later, up to four months. This condition is caused by the thickening of the circular muscles of the pylorus. Pyloric stenosis is more common in males, with an incidence of 4 per 1,000 live births. It is also more likely to affect first-borns and infants with a positive family history.

The most common symptom of pyloric stenosis is projectile vomiting, which usually occurs about 30 minutes after a feed. Other symptoms may include constipation, dehydration, and a palpable mass in the upper abdomen. Prolonged vomiting can lead to hypochloraemic, hypokalaemic alkalosis, which can be life-threatening.

Diagnosis of pyloric stenosis is typically made using ultrasound. Management of this condition involves a surgical procedure called Ramstedt pyloromyotomy. This procedure involves making a small incision in the pylorus to relieve the obstruction and allow for normal passage of food. With prompt diagnosis and treatment, infants with pyloric stenosis can make a full recovery.

The infant is suffering from pyloric stenosis, which leads to a typical imbalance of electrolytes and acid-base known as hypochloremic, hypokalaemic metabolic alkalosis. The continuous vomiting results in a gradual loss of fluids that contain hydrochloric acid, causing the kidneys to retain hydrogen ions over potassium. If the illness is brief, there may not be any electrolyte abnormalities.

Understanding Pyloric Stenosis

Pyloric stenosis is a condition that usually occurs in infants between the second and fourth weeks of life. However, in rare cases, it may present later, up to four months. This condition is caused by the thickening of the circular muscles of the pylorus. Pyloric stenosis is more common in males, with an incidence of 4 per 1,000 live births. It is also more likely to affect first-borns and infants with a positive family history.

The most common symptom of pyloric stenosis is projectile vomiting, which usually occurs about 30 minutes after a feed. Other symptoms may include constipation, dehydration, and a palpable mass in the upper abdomen. Prolonged vomiting can lead to hypochloraemic, hypokalaemic alkalosis, which can be life-threatening.

Diagnosis of pyloric stenosis is typically made using ultrasound. Management of this condition involves a surgical procedure called Ramstedt pyloromyotomy. This procedure involves making a small incision in the pylorus to relieve the obstruction and allow for normal passage of food. With prompt diagnosis and treatment, infants with pyloric stenosis can make a full recovery.

When a baby has difficulty passing stool, it may be a sign of Hirschsprung’s disease, a condition where nerve cells in the colon are missing. This disease is more common in males and can be diagnosed through a biopsy. It is important to note that not all babies with delayed passage have this disease. Hirschsprung’s disease can also present in later childhood, so it is important to ask about the timing of symptoms in children with chronic constipation or obstruction. This disease is associated with MEN 2A/B, not MEN1, and meconium ileus is a common differential. Pyloric stenosis is associated with non-bilious vomiting, while a temperature is not a factor in suggesting Hirschsprung’s disease.

Paediatric Gastrointestinal Disorders

Pyloric stenosis is more common in males and has a 5-10% chance of being inherited from parents. Symptoms include projectile vomiting at 4-6 weeks of life, and diagnosis is made through a test feed or ultrasound. Treatment involves a Ramstedt pyloromyotomy, either open or laparoscopic.

Acute appendicitis is uncommon in children under 3 years old, but when it does occur, it may present atypically. Mesenteric adenitis causes central abdominal pain and URTI, and is treated conservatively.

Intussusception occurs in infants aged 6-9 months and causes colicky pain, diarrhea, vomiting, a sausage-shaped mass, and red jelly stool. Treatment involves reduction with air insufflation.

Intestinal malrotation is characterized by a high caecum at the midline and may be complicated by the development of volvulus. Diagnosis is made through an upper GI contrast study and ultrasound, and treatment involves laparotomy or a Ladd’s procedure.

Hirschsprung’s disease occurs in 1/5000 births and is characterized by delayed passage of meconium and abdominal distension. Treatment involves rectal washouts and an anorectal pull through procedure.

Oesophageal atresia is associated with tracheo-oesophageal fistula and polyhydramnios, and may present with choking and cyanotic spells following aspiration. Meconium ileus is usually associated with cystic fibrosis and requires surgery to remove plugs. Biliary atresia causes jaundice and increased conjugated bilirubin, and requires an urgent Kasai procedure. Necrotising enterocolitis is more common in premature infants and is treated with total gut rest and TPN, with laparotomy required for perforations.

Understanding the Barlow and Ortolani Manoeuvres for Hip Dislocation Screening

Hip dislocation is a common problem in infants, and early detection is crucial for successful treatment. Two screening tests commonly used are the Barlow and Ortolani manoeuvres. The Barlow manoeuvre involves adducting the hip while applying pressure on the knee, while the Ortolani manoeuvre flexes the hips and knees to 90 degrees, with pressure applied to the greater trochanters and thumbs to abduct the legs. A positive test confirms hip dislocation, and further investigation is necessary if risk factors are present, such as breech delivery or a family history of hip problems. However, a negative test does not exclude all hip problems, and parents should seek medical advice if they notice any asymmetry or walking difficulties in their child.

Regional research programs and voluntary early-detection programs test a significant number of neonates for cystic fibrosis. While coeliac disease and type 1 diabetes mellitus are often associated due to their auto-immune nature, the recurring chest infections are not indicative of coeliac disease.

Cystic Fibrosis: Symptoms and Characteristics

Cystic fibrosis is a genetic disorder that affects various organs in the body, particularly the lungs and digestive system. The symptoms of cystic fibrosis can vary from person to person, but there are some common features that are often present. In the neonatal period, around 20% of infants with cystic fibrosis may experience meconium ileus, which is a blockage in the intestine caused by thick, sticky mucous. Prolonged jaundice may also occur, but less commonly. Recurrent chest infections are a common symptom, affecting around 40% of patients. Malabsorption is another common feature, with around 30% of patients experiencing steatorrhoea (excessive fat in the stool) and failure to thrive. Liver disease may also occur in around 10% of patients.

It is important to note that while many patients are diagnosed with cystic fibrosis during newborn screening or early childhood, around 5% of patients are not diagnosed until after the age of 18. Other features of cystic fibrosis may include short stature, diabetes mellitus, delayed puberty, rectal prolapse (due to bulky stools), nasal polyps, male infertility, and female subfertility. Overall, the symptoms and characteristics of cystic fibrosis can vary widely, but early diagnosis and treatment can help manage the condition and improve quality of life.

The presence of an ejection systolic murmur in this patient suggests that they may have Turner syndrome, which is known to cause complications such as bicuspid aortic valve. This can lead to aortic stenosis and result in the murmur. It is important to note that Turner’s syndrome does not typically affect lung development, and a mid-diastolic murmur would not be expected as a result of this condition.

Understanding Turner’s Syndrome

Turner’s syndrome is a genetic disorder that affects approximately 1 in 2,500 females. It is caused by the absence of one sex chromosome (X) or a deletion of the short arm of one of the X chromosomes. This condition is denoted as 45,XO or 45,X.

The features of Turner’s syndrome include short stature, a shield chest with widely spaced nipples, a webbed neck, a bicuspid aortic valve (15%), coarctation of the aorta (5-10%), primary amenorrhea, cystic hygroma (often diagnosed prenatally), a high-arched palate, a short fourth metacarpal, multiple pigmented naevi, lymphoedema in neonates (especially feet), and elevated gonadotrophin levels. Hypothyroidism is much more common in Turner’s syndrome, and there is also an increased incidence of autoimmune disease (especially autoimmune thyroiditis) and Crohn’s disease.

In summary, Turner’s syndrome is a chromosomal disorder that affects females and can cause a range of physical features and health issues. Early diagnosis and management can help individuals with Turner’s syndrome lead healthy and fulfilling lives.

Managing Asthma in Children: NICE Guidelines

Asthma management in children has been updated by NICE in 2017, following the 2016 BTS guidelines. The new guidelines for children aged 5-16 are similar to those for adults, with a stepwise approach for treatment. For newly-diagnosed asthma, short-acting beta agonist (SABA) is recommended. If symptoms persist, a combination of SABA and paediatric low-dose inhaled corticosteroid (ICS) is used. Leukotriene receptor antagonist (LTRA) is added if symptoms still persist, followed by long-acting beta agonist (LABA) if necessary. Maintenance and reliever therapy (MART) is used as a combination of ICS and LABA for daily maintenance therapy and symptom relief. For children under 5 years old, clinical judgement plays a greater role in diagnosis. The stepwise approach is similar to that for older children, with an 8-week trial of paediatric moderate-dose ICS before adding LTRA. If symptoms persist, referral to a paediatric asthma specialist is recommended.

It should be noted that NICE does not recommend changing treatment for well-controlled asthma patients simply to adhere to the latest guidelines. The definitions of low, moderate, and high-dose ICS have also changed, with different definitions for adults and children. For children, <= 200 micrograms budesonide or equivalent is considered a paediatric low dose, 200-400 micrograms is a moderate dose, and > 400 micrograms is a high dose. Overall, the new NICE guidelines provide a clear and concise approach to managing asthma in children.

Managing Acute Epiglottitis: Prioritizing Airway Security

Acute epiglottitis is a medical emergency that requires immediate attention to secure the patient’s airway. While medical therapies and investigations are important, the priority should be given to securing the airway via endo-/nasotracheal intubation or tracheostomy guided by a senior anaesthetist and ENT surgeon. Oral instrumentation is contraindicated until the airway has been secured. Lateral neck X-ray may be useful in diagnosing less acute presentations, but in this case, the child requires intravenous broad-spectrum antibiotics and admission to an Intensive Therapy Unit/High-dependency Unit bed in the hospital. Intubating a child with acute epiglottitis can be challenging and should only be undertaken by an experienced anaesthetist.

Understanding Pyloric Stenosis

Pyloric stenosis is a condition that usually occurs in infants between the second and fourth weeks of life. However, in rare cases, it may present later, up to four months. This condition is caused by the thickening of the circular muscles of the pylorus. Pyloric stenosis is more common in males, with an incidence of 4 per 1,000 live births. It is also more likely to affect first-borns and infants with a positive family history.

The most common symptom of pyloric stenosis is projectile vomiting, which usually occurs about 30 minutes after a feed. Other symptoms may include constipation, dehydration, and a palpable mass in the upper abdomen. Prolonged vomiting can lead to hypochloraemic, hypokalaemic alkalosis, which can be life-threatening.

Diagnosis of pyloric stenosis is typically made using ultrasound. Management of this condition involves a surgical procedure called Ramstedt pyloromyotomy. This procedure involves making a small incision in the pylorus to relieve the obstruction and allow for normal passage of food. With prompt diagnosis and treatment, infants with pyloric stenosis can make a full recovery.

Bronchiolitis in children can be managed with supportive therapy and does not require antibiotics. The patient in this case presents with typical symptoms of bronchiolitis, including a preceding coryzal phase, cough, increased work of breathing, and crackles and wheeze on auscultation. Although the patient has a mild temperature and tachypnoea, sepsis is not suspected as the normal parameters for children of this age are different. According to NICE guidelines, treatment for bronchiolitis should focus on supportive therapy, such as humidified oxygen or fluids if necessary. Salbutamol, amoxicillin, oral dexamethasone, and erythromycin are not recommended for bronchiolitis.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

Bone marrow examination is not necessary for children with immune thrombocytopenia (ITP) unless there are atypical features such as splenomegaly, bone pain, or diffuse lymphadenopathy. ITP is an autoimmune disorder that causes the destruction of platelets, often triggered by a viral illness. Folate deficiency, photophobia, and epistaxis are not indications for bone marrow biopsy in children with ITP. While photophobia may suggest meningitis in a patient with a petechial rash, it does not warrant a bone marrow biopsy. Nosebleeds are common in young children with ITP and do not require a bone marrow biopsy.

Understanding Immune Thrombocytopenia (ITP) in Children

Immune thrombocytopenic purpura (ITP) is a condition where the immune system attacks the platelets, leading to a decrease in their count. This condition is more common in children and is usually acute, often following an infection or vaccination. The antibodies produced by the immune system target the glycoprotein IIb/IIIa or Ib-V-IX complex, causing a type II hypersensitivity reaction.

The symptoms of ITP in children include bruising, a petechial or purpuric rash, and less commonly, bleeding from the nose or gums. A full blood count is usually sufficient to diagnose ITP, and a bone marrow examination is only necessary if there are atypical features.

In most cases, ITP resolves on its own within six months, without any treatment. However, if the platelet count is very low or there is significant bleeding, treatment options such as oral or IV corticosteroids, IV immunoglobulins, or platelet transfusions may be necessary. It is also advisable to avoid activities that may result in trauma, such as team sports. Understanding ITP in children is crucial for prompt diagnosis and management of this condition.

Children over the age of 12 have vital signs similar to adults. However, if a child presents with symptoms of sepsis, such as a high temperature, elevated heart rate, low blood pressure, and increased respiratory rate, it is important to initiate the sepsis six protocol and conduct further investigations to determine the source of infection. In such cases, it is not appropriate to send the child home or administer additional doses of antipyretics. Aspirin should not be given to children due to the risk of Reye’s syndrome. Broad-spectrum IV antibiotics should be administered if there is a suspected bacterial infection causing sepsis.

Age-appropriate Vital Signs for Children

Paediatric vital signs vary depending on the age of the child. The table below provides age-appropriate ranges for heart rate and respiratory rate. For children under one year old, a heart rate of 110-160 beats per minute and a respiratory rate of 30-40 breaths per minute is considered normal. For children between the ages of one and two, a heart rate of 100-150 beats per minute and a respiratory rate of 25-35 breaths per minute is normal. Children between the ages of two and five should have a heart rate of 90-140 beats per minute and a respiratory rate of 25-30 breaths per minute. For children between the ages of five and twelve, a heart rate of 80-120 beats per minute and a respiratory rate of 20-25 breaths per minute is normal. Finally, for children over the age of twelve, a heart rate of 60-100 beats per minute and a respiratory rate of 15-20 breaths per minute is considered normal. It is important for healthcare professionals to be aware of these age-appropriate vital sign ranges in order to properly assess the health of children.

It is not recommended to use corticosteroids in children under 3 months of age who have suspected or confirmed bacterial meningitis. The most common organisms causing bacterial meningitis vary depending on the age of the child. For neonates up to 3 months old, Group B streptococcus, E.coli, and Listeria monocytogenes are the most common. For children between 1 month and 6 years old, Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae are the most common. For children over 6 years old, Neisseria meningitidis and Streptococcus pneumoniae are the most common. In older children with bacterial meningitis, dexamethasone may reduce the risk of hearing loss, particularly in those with Hib meningitis. However, it should be avoided in children under 3 months old with suspected or confirmed bacterial meningitis, as well as those with certain central nervous system abnormalities or nonbacterial meningitis. Activated protein C and recombinant bacterial permeability-increasing protein should not be used in children and young people with meningococcal septicaemia. Treatment should not be delayed for a CT scan, as bacterial meningitis is a medical emergency. Intravenous immunoglobulins are not currently recommended for the management of meningitis.

Investigation and Management of Meningitis in Children

Meningitis is a serious condition that can affect children. When investigating meningitis, it is important to note any contraindications to lumbar puncture, such as signs of raised intracranial pressure, focal neurological signs, papilloedema, significant bulging of the fontanelle, disseminated intravascular coagulation, or signs of cerebral herniation. For patients with meningococcal septicaemia, a lumbar puncture is contraindicated, and blood cultures and PCR for meningococcal should be obtained instead.

The management of meningitis in children involves administering antibiotics, such as IV amoxicillin (or ampicillin) and IV cefotaxime for children under three months, and IV cefotaxime (or ceftriaxone) for children over three months. Steroids should be considered if the lumbar puncture reveals certain findings, such as purulent cerebrospinal fluid, a high white blood cell count, or bacteria on Gram stain. Fluids should be administered to treat shock, and cerebral monitoring should be conducted, including mechanical ventilation if necessary.

It is also important to notify public health authorities and administer antibiotic prophylaxis to contacts. Ciprofloxacin is now preferred over rifampicin for this purpose. Overall, prompt and appropriate management of meningitis in children is crucial for ensuring the best possible outcomes.

The correct ratio of compressions to breaths in paediatric basic life support is 15:2. If a child is unconscious and not breathing, and has a pulse rate below 60 beats per minute with signs of inadequate perfusion, CPR should be started immediately with the ratio of 15 chest compressions to 2 breaths. It is important to also seek additional help and attach defibrillator pads. Continuing to support breathing without starting CPR is not appropriate in this scenario. Placing the child in the recovery position is also not recommended as they are in cardio-respiratory arrest and require chest compressions to improve perfusion. Finally, starting CPR with a ratio of 30 chest compressions to 2 breaths is incorrect for a paediatric patient, as this ratio is used in the adult cardiac arrest algorithm.

Paediatric Basic Life Support Guidelines

Paediatric basic life support guidelines were updated in 2015 by the Resuscitation Council. Lay rescuers should use a compression:ventilation ratio of 30:2 for children under 1 year and between 1 year and puberty, a child is defined. If there are two or more rescuers, a ratio of 15:2 should be used.

The algorithm for paediatric basic life support starts with checking if the child is unresponsive and shouting for help. The airway should be opened, and breathing should be checked by looking, listening, and feeling for breaths. If the child is not breathing, five rescue breaths should be given, and signs of circulation should be checked.

For infants, the brachial or femoral pulse should be used, while children should use the femoral pulse. Chest compressions should be performed at a ratio of 15:2, with a rate of 100-120 compressions per minute for both infants and children. The depth of compressions should be at least one-third of the anterior-posterior dimension of the chest, which is approximately 4 cm for an infant and 5 cm for a child.

In children, the lower half of the sternum should be compressed, while in infants, a two-thumb encircling technique should be used for chest compressions. These guidelines are crucial for anyone who may need to perform basic life support on a child, and it is essential to follow them carefully to ensure the best possible outcome.

Neonatal death is the term used to describe the death of a baby within the first 28 days of life. This classification is important for public health interventions and is a common topic in exams. Miscarriage, on the other hand, is defined as the death of a fetus before 24 weeks of gestation in the UK, or before 28 weeks globally. Puerperal death refers to the death of a mother within the first 6 weeks after giving birth. Perinatal death is a broader term that includes stillbirths and deaths within the first week of life, often resulting from obstetric events. Early neonatal death refers to death within the first week of life, while late neonatal death refers to death after 7 days but before 28 days of life.

Perinatal Death Rates and Related Metrics

Perinatal mortality rate is a measure of stillbirths and early neonatal deaths within seven days per 1,000 births after 24 weeks of gestation. In the UK, this rate is around 6 per 1,000 births. This figure is usually broken down into 4 per 1,000 stillbirths and 2 per 1,000 early neonatal deaths.

Maternal mortality rate, on the other hand, is calculated by dividing the number of deaths during pregnancy, labor, and six weeks after delivery by the total number of maternities and multiplying the result by 1000. Meanwhile, the stillbirth rate is determined by dividing the number of babies born dead after 24 weeks by the total number of births (live and stillborn) and multiplying the result by 1000. Lastly, the neonatal death rate is computed by dividing the number of babies who died between 0-28 days by the total number of live births and multiplying the result by 1000.

These metrics are important in assessing the quality of perinatal care and identifying areas for improvement. By monitoring these rates, healthcare providers can work towards reducing perinatal deaths and improving maternal and neonatal outcomes.

Chickenpox and its Complications

Chickenpox can lead to various complications, including invasive group A streptococcal soft tissue infections such as necrotizing fasciitis. This rare complication of the varicella-zoster virus causes painful lesions on the skin and underlying muscles, with systemic symptoms and open wounds. Diagnosis is made by passing a probe or gloved finger below the affected skin, causing it to separate from the underlying tissue.

Another complication caused by group A streptococcus is cellulitis, which affects the dermis and subcutaneous tissue. It presents with erythema, pain, swelling, and warmth, without systemic symptoms. Erysipelas, on the other hand, is a bacterial infection that affects the superficial layer of the dermis and commonly affects superficial cutaneous lymphatics. It presents similarly to cellulitis but has well-defined borders and can be a rare complication of chickenpox.

Henoch-Schonlein Purpura is an IgA-mediated vasculitis of the small vessels of the skin. It can rarely present as a complication of chickenpox with a widespread rash on the buttocks and lower thigh, abdominal pain, and joint pain. Reyes syndrome is another complication that commonly presents after a recent viral infection such as chickenpox. It is also thought to be triggered by aspirin use, which is often used to treat the symptoms of chickenpox, such as headaches. It presents with tachypnea, tiredness, and in severe cases can cause behavioral changes and coma. However, in this case, the patient only presents with tachypnea, and there is no evidence to suggest the use of aspirin.

Chickenpox: Causes, Symptoms, and Management

Chickenpox is a viral infection caused by the varicella zoster virus. It is highly contagious and can be spread through respiratory droplets. The virus can also reactivate later in life, causing shingles. Chickenpox is most infectious four days before the rash appears and until five days after the rash first appears. The incubation period is typically 10-21 days. Symptoms include fever, an itchy rash that starts on the head and trunk before spreading, and mild systemic upset.

Management of chickenpox is supportive and includes keeping cool, trimming nails, and using calamine lotion. School exclusion is recommended during the infectious period. Immunocompromised patients and newborns with peripartum exposure should receive varicella zoster immunoglobulin (VZIG). If chickenpox develops, IV acyclovir may be considered. Secondary bacterial infection of the lesions is a common complication, which may be increased by the use of NSAIDs. In rare cases, invasive group A streptococcal soft tissue infections may occur, resulting in necrotizing fasciitis. Other rare complications include pneumonia, encephalitis, disseminated haemorrhagic chickenpox, arthritis, nephritis, and pancreatitis.

Radiographic Findings in Varicella Pneumonia

Varicella pneumonia is a rare complication of chickenpox that can occur in immunocompromised patients or adults. Radiographic findings of healed varicella pneumonia may include miliary opacities throughout both lungs, which are of uniform size and dense, suggesting calcification. There is typically no focal lung parenchymal mass or cavitating lesion seen. These findings are characteristic of healed varicella pneumonia.

Understanding Vesicoureteric Reflux

Vesicoureteric reflux (VUR) is a condition where urine flows back from the bladder into the ureter and kidney. This is a common urinary tract abnormality in children and can lead to urinary tract infections (UTIs). In fact, around 30% of children who present with a UTI have VUR. It is important to investigate for VUR in children following a UTI as around 35% of children develop renal scarring.

The pathophysiology of VUR involves the ureters being displaced laterally, which causes a shortened intramural course of the ureter. This means that the vesicoureteric junction cannot function properly. VUR can present in different ways, such as hydronephrosis on ultrasound during the antenatal period, recurrent childhood UTIs, and reflux nephropathy, which is chronic pyelonephritis secondary to VUR. Renal scarring can also produce increased quantities of renin, which can cause hypertension.

To diagnose VUR, a micturating cystourethrogram is usually performed. A DMSA scan may also be done to check for renal scarring. VUR is graded based on the severity of the condition, with Grade I being the mildest and Grade V being the most severe.

Overall, understanding VUR is important in preventing complications such as UTIs and renal scarring. Early diagnosis and management can help improve outcomes for children with this condition.

The presented history indicates a possible case of meconium ileus, where the thickened meconium caused a blockage in the small intestine due to cystic fibrosis. The neonate is likely to have a swollen abdomen and may not pass meconium. Vomiting may contain bile, which is different from pyloric stenosis that does not have bile. Additionally, there is no indication of intussusception or pyloric stenosis mass.

Cystic Fibrosis: Symptoms and Characteristics

Cystic fibrosis is a genetic disorder that affects various organs in the body, particularly the lungs and digestive system. The symptoms of cystic fibrosis can vary from person to person, but there are some common features that are often present. In the neonatal period, around 20% of infants with cystic fibrosis may experience meconium ileus, which is a blockage in the intestine caused by thick, sticky mucous. Prolonged jaundice may also occur, but less commonly. Recurrent chest infections are a common symptom, affecting around 40% of patients. Malabsorption is another common feature, with around 30% of patients experiencing steatorrhoea (excessive fat in the stool) and failure to thrive. Liver disease may also occur in around 10% of patients.

It is important to note that while many patients are diagnosed with cystic fibrosis during newborn screening or early childhood, around 5% of patients are not diagnosed until after the age of 18. Other features of cystic fibrosis may include short stature, diabetes mellitus, delayed puberty, rectal prolapse (due to bulky stools), nasal polyps, male infertility, and female subfertility. Overall, the symptoms and characteristics of cystic fibrosis can vary widely, but early diagnosis and treatment can help manage the condition and improve quality of life.

The patient’s presentation is consistent with androgen insensitivity, which is a genetic condition where individuals with XY chromosomes have female physical characteristics due to a lack of testosterone receptors in their tissues. This disorder is X-linked and often results in undescended testes. Congenital adrenal hyperplasia is unlikely as it typically causes early puberty and virilization, while Kallmann syndrome does not explain the presence of groin masses. Polycystic ovarian syndrome usually results in secondary amenorrhea or oligomenorrhea and is accompanied by other symptoms such as acne and hirsutism. Turner’s syndrome, which causes primary amenorrhea, is characterized by short stature, webbed neck, heart defects, and abnormal breast development, and does not involve undescended testes.

Disorders of sex hormones can have various effects on the body, as shown in the table below. Primary hypogonadism, also known as Klinefelter’s syndrome, is characterized by high levels of LH and low levels of testosterone. Patients with this disorder often have small, firm testes, lack secondary sexual characteristics, and are infertile. They may also experience gynaecomastia and have an increased risk of breast cancer. Diagnosis is made through chromosomal analysis.

Hypogonadotrophic hypogonadism, or Kallmann syndrome, is another cause of delayed puberty. It is typically inherited as an X-linked recessive trait and is caused by the failure of GnRH-secreting neurons to migrate to the hypothalamus. Patients with Kallmann syndrome may have hypogonadism, cryptorchidism, and anosmia. Sex hormone levels are low, and LH and FSH levels are inappropriately low or normal. Cleft lip/palate and visual/hearing defects may also be present.

Androgen insensitivity syndrome is an X-linked recessive condition that causes end-organ resistance to testosterone, resulting in genotypically male children (46XY) having a female phenotype. Complete androgen insensitivity syndrome is the new term for testicular feminisation syndrome. Patients with this disorder may experience primary amenorrhoea, undescended testes causing groin swellings, and breast development due to the conversion of testosterone to oestradiol. Diagnosis is made through a buccal smear or chromosomal analysis to reveal a 46XY genotype. Management includes counseling to raise the child as female, bilateral orchidectomy due to an increased risk of testicular cancer from undescended testes, and oestrogen therapy.

To promote duct closure in patent ductus arteriosus, indomethacin or ibuprofen is used.

The incomplete closure of the ductus arteriosus after birth is known as patent ductus arteriosus (PDA), which is causing the patient’s symptoms. During fetal development, this vessel allows blood to bypass the immature fetal lungs. However, if the duct remains open after birth, a large amount of blood can bypass the functioning lungs, resulting in reduced oxygen saturation and a murmur.

Prostaglandin E2 maintains the ductus arteriosus, so medications like indomethacin or ibuprofen, which inhibit prostaglandin synthesis, can be effective in closing the duct. However, in some cases, surgery may be necessary to close particularly large PDAs.

Patent ductus arteriosus is a type of congenital heart defect that is typically classified as ‘acyanotic’. However, if left untreated, it can eventually lead to late cyanosis in the lower extremities, which is known as differential cyanosis. This condition is caused by a connection between the pulmonary trunk and descending aorta that fails to close with the first breaths due to increased pulmonary flow that enhances prostaglandins clearance. Patent ductus arteriosus is more common in premature babies, those born at high altitude, or those whose mothers had rubella infection during the first trimester of pregnancy.

The features of patent ductus arteriosus include a left subclavicular thrill, a continuous ‘machinery’ murmur, a large volume, bounding, collapsing pulse, a wide pulse pressure, and a heaving apex beat. To manage this condition, indomethacin or ibuprofen is given to the neonate, which inhibits prostaglandin synthesis and closes the connection in the majority of cases. If patent ductus arteriosus is associated with another congenital heart defect that is amenable to surgery, then prostaglandin E1 is useful to keep the duct open until after surgical repair.

His respiratory rate and heart rate are both within normal limits, with a respiratory rate of less than 30 breaths per minute and a heart rate of less than 125 beats per minute. The appropriate treatment for his asthma attack is oral prednisolone and salbutamol via a spacer, with one puff administered every 30-60 seconds up to a maximum of 10 puffs. It is important to administer steroid therapy to all children experiencing an asthma attack. The use of high flow oxygen and a salbutamol nebuliser is not necessary, as his SP02 is already at 97%.

Managing Acute Asthma Attacks in Children

When it comes to managing acute asthma attacks in children, it is important to assess the severity of the attack and take appropriate action. For children between the ages of 2 and 5, those with severe or life-threatening asthma should be immediately transferred to the hospital. For moderate attacks, children should have a SpO2 level above 92% and no clinical features of severe asthma. However, for severe attacks, children may have a SpO2 level below 92%, be too breathless to talk or feed, have a heart rate above 140/min, and use accessory neck muscles. For life-threatening attacks, children may have a SpO2 level below 92%, a silent chest, poor respiratory effort, agitation, altered consciousness, and cyanosis.

For children over the age of 5, it is recommended to attempt to measure PEF in all cases. For moderate attacks, children should have a SpO2 level above 92%, a PEF level above 50% best or predicted, and no clinical features of severe asthma. For severe attacks, children may have a SpO2 level below 92%, a PEF level between 33-50% best or predicted, and be unable to complete sentences in one breath or too breathless to talk or feed. For life-threatening attacks, children may have a SpO2 level below 92%, a PEF level below 33% best or predicted, a silent chest, poor respiratory effort, altered consciousness, and cyanosis.

For children with mild to moderate acute asthma, bronchodilator therapy should be given via a beta-2 agonist and spacer (or close-fitting mask for children under 3 years old). One puff should be given every 30-60 seconds up to a maximum of 10 puffs. If symptoms are not controlled, the beta-2 agonist should be repeated and the child should be referred to the hospital. Steroid therapy should also be given to all children with an asthma exacerbation for 3-5 days, with the usual prednisolone dose varying based on age and weight.

If a foetus is diagnosed with exomphalos before birth, it is recommended to schedule and perform a caesarean section at term to reduce the risk of sac rupture, infection, and atresia. While a ward delivery provides access to theatres, specific surgical planning is necessary to minimize complications. Instrumental delivery in theatre does not decrease the risk of sac rupture. It is important to explain to the mother why hospital delivery is necessary and the risks associated with a home birth. Induction of labour at 37 weeks is not advisable as it increases the risk of complications during vaginal delivery.

Gastroschisis and exomphalos are both types of congenital visceral malformations. Gastroschisis refers to a defect in the anterior abdominal wall located just beside the umbilical cord. In contrast, exomphalos, also known as omphalocoele, involves the protrusion of abdominal contents through the anterior abdominal wall, which are covered by an amniotic sac formed by amniotic membrane and peritoneum.

When it comes to managing gastroschisis, vaginal delivery may be attempted, but newborns should be taken to the operating theatre as soon as possible after delivery, ideally within four hours. As for exomphalos, a caesarean section is recommended to reduce the risk of sac rupture. In cases where primary closure is difficult due to lack of space or high intra-abdominal pressure, a staged repair may be undertaken. This involves allowing the sac to granulate and epithelialise over several weeks or months, forming a shell. As the infant grows, the sac contents will eventually fit within the abdominal cavity, at which point the shell can be removed and the abdomen closed.

Overall, both gastroschisis and exomphalos require careful management to ensure the best possible outcome for the newborn. By understanding the differences between these two conditions and the appropriate steps to take, healthcare professionals can provide effective care and support to both the infant and their family.

It is typical for newborns to experience temporary hypoglycaemia during the first few hours after birth. However, infants born to mothers with diabetes (whether gestational or pre-existing) are at a higher risk of developing this condition. This is due to the fact that high blood sugar levels in the mother during labour can trigger the release of insulin in the foetus, and once born, the baby no longer has a constant supply of glucose from the mother.

Fortunately, in most cases, transient hypoglycaemia does not require any medical intervention and is closely monitored. It is recommended that mothers feed their newborns early and at regular intervals. For babies born to diabetic mothers, a hypoglycaemia protocol will be initiated and discontinued once the infant has at least three blood glucose readings above 2.5 mmol/L and is feeding appropriately.

Neonatal Hypoglycaemia: Causes, Symptoms, and Management

Neonatal hypoglycaemia is a common condition in newborn babies, especially in the first 24 hours of life. While there is no agreed definition, a blood glucose level of less than 2.6 mmol/L is often used as a guideline. Transient hypoglycaemia is normal and usually resolves on its own, but persistent or severe hypoglycaemia may be caused by various factors such as preterm birth, maternal diabetes mellitus, IUGR, hypothermia, neonatal sepsis, inborn errors of metabolism, nesidioblastosis, or Beckwith-Wiedemann syndrome.

Symptoms of neonatal hypoglycaemia can be autonomic, such as jitteriness, irritability, tachypnoea, and pallor, or neuroglycopenic, such as poor feeding/sucking, weak cry, drowsiness, hypotonia, and seizures. Other features may include apnoea and hypothermia. Management of neonatal hypoglycaemia depends on the severity of the condition and whether the newborn is symptomatic or not. Asymptomatic babies can be encouraged to feed normally and have their blood glucose monitored, while symptomatic or severely hypoglycaemic babies may need to be admitted to the neonatal unit and receive intravenous infusion of 10% dextrose.

Management of Infantile Pyloric Stenosis: Correcting Metabolic Derangements

Infantile pyloric stenosis is a condition that affects 3-4/1000 live births, with a higher incidence in males and first-born babies. The condition is characterized by an increase in the length and diameter of the pylorus, with hypertrophy of the circular muscle layer and autonomic nerves. The classical electrolyte abnormality associated with infantile pyloric stenosis is hypokalaemic hypochloraemic alkalosis.

Before undertaking surgery, it is crucial to correct the metabolic abnormalities in consultation with an experienced paediatrician and anaesthetist. Jaundice may also occur in 2-3% of infants with pyloric stenosis due to a decrease in hepatic glucuronosyltransferase activity associated with starvation.

The tumour is typically diagnosed clinically as a palpable tumour on test feed alongside a history of projectile vomiting and hungry feeding without bile in the vomitus. Upper GI endoscopy may not be necessary if the diagnosis is clear.

Feeding jejunostomy is not appropriate initial management for infantile pyloric stenosis. The definitive surgical treatment is Ramstedt’s pyloromyotomy, which involves excluding the umbilicus from the operative field due to the risk of staphylococcus aureus infection. Total parenteral nutrition may be ill-advised given the significant electrolyte derangements associated with the condition.

In summary, correcting metabolic derangements is crucial before undertaking surgery for infantile pyloric stenosis. The definitive treatment is Ramstedt’s pyloromyotomy, and other management options should be carefully considered in consultation with experienced healthcare professionals.

Dealing with Safeguarding Concerns as an FY2 Doctor

As an FY2 doctor, it is important to know how to handle safeguarding concerns appropriately. If you have any concerns about a patient’s welfare, it is crucial to follow the correct protocol to ensure their safety. Here are some options for dealing with safeguarding concerns:

1. Discuss the case with the safeguarding lead in the department. It is always best to seek advice from someone with more experience in this area.

2. Contact the police if you are concerned about the current safety of a patient. However, if the child is in the department, they can be considered to be in a place of safety.

3. Do not investigate the allegations yourself. This could put the child at increased risk. Instead, follow the correct protocol for dealing with safeguarding concerns.

4. If you have concerns regarding a child’s welfare, ensure you have followed the correct protocol and be confident that it is safe to discharge them. Always discuss your concerns with the safeguarding lead.

5. If you are going to make a referral to social services, try to gain consent from the parent or patient. If consent is refused, the referral can still be made, but it is important to inform the patient or parent of your actions.

Remember, as an FY2 doctor, you are still inexperienced, and it is important to seek advice and guidance from more experienced colleagues when dealing with safeguarding concerns.

Assessing Acute Asthma Attacks in Children

When assessing the severity of asthma attacks in children, the 2016 BTS/SIGN guidelines recommend using specific criteria. These criteria can help determine whether the attack is severe or life-threatening. For a severe attack, the child may have a SpO2 level below 92%, a PEF level between 33-50% of their best or predicted, and may be too breathless to talk or feed. Additionally, their heart rate may be over 125 (for children over 5 years old) or over 140 (for children between 1-5 years old), and their respiratory rate may be over 30 breaths per minute (for children over 5 years old) or over 40 (for children between 1-5 years old). They may also be using accessory neck muscles to breathe.

For a life-threatening attack, the child may have a SpO2 level below 92%, a PEF level below 33% of their best or predicted, and may have a silent chest, poor respiratory effort, agitation, altered consciousness, or cyanosis. It is important for healthcare professionals to be aware of these criteria and to take appropriate action to manage the child’s asthma attack. By following these guidelines, healthcare professionals can help ensure that children with asthma receive the appropriate care and treatment they need during an acute attack.

The patient’s symptoms of fever, maculopapular rash, and koplik spots suggest a diagnosis of measles. The most common complication of measles is otitis media, which can cause unilateral ear pain, fever, and redness/swelling of the tympanic membrane. While bronchitis and encephalitis are possible complications of measles, they are less common than otitis media. Meningitis is also a serious complication of measles, but it typically presents with different symptoms such as neck stiffness and a non-blanching rash. Orchitis, which causes scrotal pain, is a complication of mumps rather than measles.

Measles: A Highly Infectious Viral Disease

Measles is a viral disease caused by an RNA paramyxovirus. It is one of the most infectious known viruses and is spread through aerosol transmission. The disease has an incubation period of 10-14 days and is infective from the prodromal phase until four days after the rash starts. Measles is now rare in developed countries due to immunization programs, but outbreaks can occur when vaccination rates drop, such as during the MMR controversy of the early 2000s.

The disease is characterized by a prodromal phase, which includes irritability, conjunctivitis, fever, and Koplik spots. The latter typically develop before the rash and are white spots on the buccal mucosa. The rash starts behind the ears and then spreads to the whole body, becoming a discrete maculopapular rash that may become blotchy and confluent. Desquamation may occur after a week, typically sparing the palms and soles. Diarrhea occurs in around 10% of patients.

Measles is mainly managed through supportive care, and admission may be considered in immunosuppressed or pregnant patients. The disease is notifiable, and public health should be informed. Complications of measles include otitis media, pneumonia (the most common cause of death), encephalitis (typically occurring 1-2 weeks following the onset of the illness), subacute sclerosing panencephalitis (very rare, may present 5-10 years following the illness), febrile convulsions, keratoconjunctivitis, corneal ulceration, diarrhea, increased incidence of appendicitis, and myocarditis.

If an unimmunized child comes into contact with measles, MMR should be offered within 72 hours. Vaccine-induced measles antibody develops more rapidly than that following natural infection.

If the unborn baby has exomphalos, it is recommended to opt for a caesarean section to minimize the chances of sac rupture. The presence of a membrane containing the abdominal content suggests that the baby is likely to have exomphalos. While vaginal delivery is possible, a caesarean section is the safest delivery option. There is no need for an emergency caesarean section as the baby is not experiencing any distress. Inducing labor for vaginal delivery is not advisable, and a caesarean section is a better option. Additionally, IM corticosteroids are not necessary as there is no risk of premature delivery at present. These steroids are typically used when women are at risk of or experience premature labor.

Gastroschisis and exomphalos are both types of congenital visceral malformations. Gastroschisis refers to a defect in the anterior abdominal wall located just beside the umbilical cord. In contrast, exomphalos, also known as omphalocoele, involves the protrusion of abdominal contents through the anterior abdominal wall, which are covered by an amniotic sac formed by amniotic membrane and peritoneum.

When it comes to managing gastroschisis, vaginal delivery may be attempted, but newborns should be taken to the operating theatre as soon as possible after delivery, ideally within four hours. As for exomphalos, a caesarean section is recommended to reduce the risk of sac rupture. In cases where primary closure is difficult due to lack of space or high intra-abdominal pressure, a staged repair may be undertaken. This involves allowing the sac to granulate and epithelialise over several weeks or months, forming a shell. As the infant grows, the sac contents will eventually fit within the abdominal cavity, at which point the shell can be removed and the abdomen closed.

Overall, both gastroschisis and exomphalos require careful management to ensure the best possible outcome for the newborn. By understanding the differences between these two conditions and the appropriate steps to take, healthcare professionals can provide effective care and support to both the infant and their family.

If the neonate is not showing any symptoms and the blood glucose levels are not significantly low, the recommended approach for neonatal hypoglycaemia is to monitor glucose levels and encourage normal feeding. As the mother is diabetic, the neonate is at a higher risk of developing hypoglycaemia. However, administering oral glucose is not necessary at this stage. Admission to the neonatal unit and dextrose infusion would be necessary if the blood glucose levels drop significantly or if the neonate shows symptoms of hypoglycaemia. Intramuscular glucagon would only be considered if the neonate is symptomatic and unable to receive dextrose through IV access. The guidelines do not recommend exclusively bottle-feeding for the next 24 hours.

Neonatal Hypoglycaemia: Causes, Symptoms, and Management

Neonatal hypoglycaemia is a common condition in newborn babies, especially in the first 24 hours of life. While there is no agreed definition, a blood glucose level of less than 2.6 mmol/L is often used as a guideline. Transient hypoglycaemia is normal and usually resolves on its own, but persistent or severe hypoglycaemia may be caused by various factors such as preterm birth, maternal diabetes mellitus, IUGR, hypothermia, neonatal sepsis, inborn errors of metabolism, nesidioblastosis, or Beckwith-Wiedemann syndrome.

Symptoms of neonatal hypoglycaemia can be autonomic, such as jitteriness, irritability, tachypnoea, and pallor, or neuroglycopenic, such as poor feeding/sucking, weak cry, drowsiness, hypotonia, and seizures. Other features may include apnoea and hypothermia. Management of neonatal hypoglycaemia depends on the severity of the condition and whether the newborn is symptomatic or not. Asymptomatic babies can be encouraged to feed normally and have their blood glucose monitored, while symptomatic or severely hypoglycaemic babies may need to be admitted to the neonatal unit and receive intravenous infusion of 10% dextrose.

The definitive test for diagnosing necrotising enterocolitis is an abdominal x-ray. If the x-ray shows pneumatosis intestinalis (gas in the gut wall), it confirms the presence of NEC. Treatment involves stopping oral feeds, providing barrier nursing, and administering antibiotics such as cefotaxime and vancomycin. In severe cases, a laparotomy may be necessary, but this is a poor prognostic indicator and is not performed for diagnostic purposes. While a stool culture is often performed in cases of NEC, it is not a definitive test. It is important not to confuse NEC with intussusception, which typically affects older children (5-12 months) and presents with a distended abdomen and the passage of red currant jelly stool. In such cases, an ultrasound scan is usually the initial investigation and will show a target sign. A digital rectal exam is not a diagnostic test and only confirms the presence of feces in the rectum.

Understanding Necrotising Enterocolitis

Necrotising enterocolitis is a serious condition that is responsible for a significant number of premature infant deaths. The condition is characterized by symptoms such as feeding intolerance, abdominal distension, and bloody stools. If left untreated, these symptoms can quickly progress to more severe symptoms such as abdominal discolouration, perforation, and peritonitis.

To diagnose necrotising enterocolitis, doctors often use abdominal x-rays. These x-rays can reveal a number of important indicators of the condition, including dilated bowel loops, bowel wall oedema, and intramural gas. Other signs that may be visible on an x-ray include portal venous gas, pneumoperitoneum resulting from perforation, and air both inside and outside of the bowel wall. In some cases, an x-ray may also reveal air outlining the falciform ligament, which is known as the football sign.

Overall, understanding the symptoms and diagnostic indicators of necrotising enterocolitis is crucial for early detection and treatment of this serious condition. By working closely with healthcare professionals and following recommended screening protocols, parents and caregivers can help ensure the best possible outcomes for premature infants at risk for this condition.